These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vasodilators in left ventricular failure. Camerini F, Mestroni L, Neri R, Humar F. G Ital Cardiol; 1984 Sep; 14(9):685-93. PubMed ID: 6510623 [Abstract] [Full Text] [Related]
6. [The treatment of congestive heart failure by using vasodilators. I. Physiological basis. Different vasodilators (author's transl)]. Solignac A. Nouv Presse Med; 1978 Mar 25; 7(12):1013-20. PubMed ID: 96422 [Abstract] [Full Text] [Related]
7. Outflow resistance as a regulator of left ventricular performance. Franciosa JA. Angiology; 1978 May 25; 29(5):393-401. PubMed ID: 655470 [No Abstract] [Full Text] [Related]
8. Afterload reduction in the treatment of cardiac failure. Mason DT. Schweiz Med Wochenschr; 1978 Nov 04; 108(44):1695-703. PubMed ID: 102028 [Abstract] [Full Text] [Related]
9. Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination. Ribner HS, Zucker MJ, Stasior C, Talentowski D, Stadnicki R, Lesch M. Am Heart J; 1987 Jul 04; 114(1 Pt 1):91-6. PubMed ID: 3604877 [Abstract] [Full Text] [Related]
10. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs. Packer M, Medina N, Yushak M. Am Heart J; 1982 Nov 04; 104(5 Pt 2):1215-23. PubMed ID: 6753552 [Abstract] [Full Text] [Related]
11. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure. Mehta J, Iacona M, Pepine CJ, Conti CR. Br Heart J; 1979 Dec 04; 42(6):664-70. PubMed ID: 534583 [Abstract] [Full Text] [Related]
12. Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure. Chatterjee K, Parmley WW. J Am Coll Cardiol; 1983 Jan 04; 1(1):133-53. PubMed ID: 6338075 [Abstract] [Full Text] [Related]
13. Differential hemodynamic and sympathoadrenal effects of sodium nitroprusside and hydralazine in hypertensive subjects. Shepherd AM, Irvine NA. J Cardiovasc Pharmacol; 1986 Jan 04; 8(3):527-33. PubMed ID: 2425168 [Abstract] [Full Text] [Related]
14. Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study. Brent BN, Berger HJ, Matthay RA, Mahler D, Pytlik L, Zaret BL. Am J Cardiol; 1983 Jun 04; 51(10):1682-9. PubMed ID: 6407295 [Abstract] [Full Text] [Related]
15. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function. Capomolla S, Pozzoli M, Opasich C, Febo O, Riccardi G, Salvucci F, Maestri R, Sisti M, Cobelli F, Tavazzi L. Am Heart J; 1997 Dec 04; 134(6):1089-98. PubMed ID: 9424070 [Abstract] [Full Text] [Related]
16. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance. Miller RR, Vismara LA, Zelis R, Amsterdam EA, Mason DT. Circulation; 1975 Feb 04; 51(2):328-36. PubMed ID: 1112013 [Abstract] [Full Text] [Related]
17. Hemodynamic effects of nitroprusside and hydralazine in experimental cardiac tamponade. Fowler NO, Gabel M, Holmes JC. Circulation; 1978 Mar 04; 57(3):563-7. PubMed ID: 624165 [Abstract] [Full Text] [Related]
18. [Acute and chronic cardiac decompensation: is vasodilator therapy useful?]. Malacco E, Limonta A, Milanesi A, Micossi P. Minerva Med; 1982 Jan 14; 73(1-2):25-32. PubMed ID: 7058000 [Abstract] [Full Text] [Related]